De novo mutations in human CNOT3 cause severe neurodevelopmental deficiencies characterized by a spectrum of intellectual disability, speech delay, seizures, and behavioral problems [24–30]. Here, CNOT3 is linked to hyperinsulinemic hypoglycemia, familial, 4.